Passa al contenuto
Merck

Human Papillomavirus Quasivirus Production and Infection of Primary Human Keratinocytes.

Current protocols in microbiology (2020-05-08)
Samuel S Porter, Alison A McBride
ABSTRACT

This protocol describes the production of human papillomavirus (HPV)-derived quasiviruses. Quasiviruses are infectious particles that are produced in 293TT packaging cells and contain a complete viral genome. We describe methods for infection of primary human keratinocytes with HPV quasiviruses, as well as assays to measure early viral DNA replication and transcription. Published 2020. U.S. Government. Basic Protocol 1: Transfection, harvest, and isolation of HPV quasiviruses Alternate Protocol 1: Packaging HPV DNA replicated in 293TT cells Alternate Protocol 2: Production of higher-purity quasivirus using the "Ripcord" method Support Protocol 1: Production of HPV minicircles Support Protocol 2: Production of recircularized HPV genomes Support Protocol 3: Screening of fractions for viral proteins Support Protocol 4: Screening of fractions for viral DNA Support Protocol 5: Measuring viral titer Support Protocol 6: Quantitation of quasivirions Basic Protocol 2: Infection of primary human foreskin keratinocytes with quasivirus Basic Protocol 3: HPV quasivirus transcription assay Basic Protocol 4: HPV quasivirus replication assay.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
OptiPrep mezzo a gradiente di densità, used for cell and subcellular organelle isolation
Sigma-Aldrich
Triton X-100, for molecular biology
Sigma-Aldrich
Idrossido di sodio, 1.0 N, BioReagent, suitable for cell culture
Roche
Igromicina B, from Streptomyces hygroscopicus
Sigma-Aldrich
2-mercaptoetanolo, BioUltra, for molecular biology, ≥99.0% (GC)
Sigma-Aldrich
Kanamycin solution from Streptomyces kanamyceticus, 50 - 60 mg/mL in 0.9% NaCl, BioReagent, liquid, 0.1 μm filtered, suitable for cell culture
Sigma-Aldrich
Hydrocortisone, ≥98% (HPLC)